Evidence map›Paper›PMID 29073177›Full record

ArticlePloS one2017

Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene.

Yuan-Wan Sun, Kun-Ming Chen, Yuka Imamura Kawasawa, Anna C Salzberg, Timothy K Cooper, Carla Caruso, Cesar Aliaga, Junjia Zhu, Krishne Gowda, Shantu Amin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuan-Wan SunDepartment of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Kun-Ming ChenDepartment of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Yuka Imamura KawasawaDepartment of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Anna C SalzbergInstitute for Personalized Medicine, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Timothy K CooperDepartment of Comparative Medicine, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Carla CarusoDepartment of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Cesar AliagaDepartment of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Junjia ZhuDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Krishne GowdaDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Shantu AminDepartment of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Karam El-BayoumyDepartment of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.ORCID http://orcid.org/0000-0002-4198-0696
Pennsylvania State University · US

Funding

Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational StudiesR01CA173465 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI EL-BAYOUMY, KARAM E · 2013 to 2024
$3.1M
NCI NIH HHS R01 CA173465
6 · The paper itself

Abstract

Genetic and epigenetic alterations observed at end stage OSCC formation could be considered as a consequence of cancer development and thus changes in normal or premalignant tissues which had been exposed to oral carcinogens such as Dibenzo[def,p]chrysene (DBP) may better serve as predictive biomarkers of disease development. Many types of DNA damage can induce epigenetic changes which can occur early and in the absence of evident morphological abnormalities. Therefore we used ERRBS to generate genome-scale, single-base resolution DNA methylomes from histologically normal oral tissues of mice treated with DBP under experimental conditions known to induce maximum DNA damage which is essential for the development of OSCC induced by DBP in mice. After genome-wide correction, 30 and 48 differentially methylated sites (DMS) were identified between vehicle control and DBP treated mice using 25% and 10% differences in methylation, respectively. RT-PCR was further performed to examine the expressions of nine selected genes. Among them, Fgf3, a gene frequently amplified in head and neck cancer, showed most prominent and significant gene expression change (2.4× increases), despite the hypomethylation of Fgf3 was identified at >10kb upstream of transcription start site. No difference was observed in protein expression between normal oral tissues treated with DBP or vehicle as examined by immunohistochemistry. Collectively, our results indicate that Fgf3 hypomethylation and gene overexpression, but not protein expression, occurred in the early stage of oral carcinogenesis induced by DBP. Thus, Fgf3 hypomethylation may serve as a potential biomarker for early detection of OSCC.

Indexed as

AnimalsBenzopyrenesBiomarkers, TumorCarcinogensCarcinoma, Squamous CellDNA MethylationEarly Detection of CancerFemaleFibroblast Growth Factor 3MiceMouth NeoplasmsNicotianaReal-Time Polymerase Chain ReactionBenzopyrenesBiomarkers, TumorCarcinogensdibenzo(a,l)pyreneFgf3 protein, mouseFibroblast Growth Factor 3

Identifiers

PMID29073177
PMCPMC5658092
OpenAlexW2766605538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.